Avanos Medical (AVNS) Other Non-Current Assets (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Other Non-Current Assets data on file, last reported at $32.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 29.53% year-over-year to $32.9 million; the trailing twelve-month figure through Mar 2026 stood at $32.9 million (up 29.53% YoY), and the FY2025 full-year result was $31.5 million, up 35.78% from the prior year.
• Other Non-Current Assets rose to $32.9 million in Q1 2026, from $31.5 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $182.3 million in Q4 2022 to a low of $15.9 million in Q1 2022.
• A 5-year average of $43.3 million and a median of $25.8 million in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets jumped 1004.85% in 2022 and tumbled 74.73% in 2024, its largest moves.
• Tracing AVNS's Other Non-Current Assets over 5 years: stood at $182.3 million in 2022, then plunged by 64.62% to $64.5 million in 2023, then plunged by 64.03% to $23.2 million in 2024, then jumped by 35.78% to $31.5 million in 2025, then gained by 4.44% to $32.9 million in 2026.
• Business Quant data shows AVNS's Other Non-Current Assets at $32.9 million in Q1 2026, $31.5 million in Q4 2025, and $29.3 million in Q3 2025.